William B. Walkup & Associates’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8K Sell
860
-8
-0.9% -$109 0.01% 130
2026
Q2
$11.8K Sell
868
-597
-41% -$7.14K 0.01% 135
2026
Q1
$21.8K Buy
1,465
+240
+20% +$1.81K 0.01% 117
2025
Q4
$8.78K Sell
1,225
-240
-16% -$1.9K ﹤0.01% 137
2025
Q3
$15.6K Hold
1,465
– – 0.01% 125
2025
Q2
$14.2K Hold
1,465
– – 0.01% 125
2025
Q1
$21.8K Sell
1,465
-35
-2% -$538 0.01% 116
2024
Q4
$22.4K Hold
1,500
– – 0.01% 116
2024
Q3
$28.7K Sell
1,500
-14
-0.9% -$290 0.02% 108
2024
Q2
$31.3K Buy
+1,514
New +$30.1K 0.02% 107

Other funds holding OGN

William B. Walkup & Associates's OGN Position: Q3 2026 in Review

William B. Walkup & Associates reduced its Organon & Co (OGN) stake by 0.92% in Q3 2026, selling an estimated $109 and leaving 860 shares worth $11.8K. The position accounts for 0.01% of the portfolio, ranked #130.

William B. Walkup & Associates first reported a position in OGN in Q2 2024 and has held it in 10 quarters since. The position peaked at $31.3K in Q2 2024. 507 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • William B. Walkup & Associates held 860 shares of Organon & Co worth $11.8K as of Q3 2026.
  • William B. Walkup & Associates sold 8 Organon & Co shares in Q3 2026, an estimated $109.
  • Organon & Co made up 0.01% of William B. Walkup & Associates's portfolio in Q3 2026, its #130 holding.
  • William B. Walkup & Associates first reported a position in Organon & Co in Q2 2024 and has held it in 10 quarters since.
  • William B. Walkup & Associates's Organon & Co position peaked at $31.3K in Q2 2024.
  • 507 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on William B. Walkup & Associates's 13F filing for Q3 2026, filed 5 Nov 2026.